Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 1997Antimicrobial Agents and ChemotherapyOpen Access

Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

CDCameron DouglasMassachusetts General HospitalJDJoseph A. D'IppolitoMerck & Co., Inc., Rahway, NJ, USA (United States)GSG.-J. SheiMerck & Co., Inc., Rahway, NJ, USA (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Douglas et al. (1997) studied this question.

synapsesocial.com/papers/6a6fe9ba26a7f98052dc79efhttps://doi.org/10.1128/aac.41.11.2471
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Isolation of a gene involved in 1,3-beta-glucan synthesis in Aspergillus nidulans and purification of the corresponding protein1996 · 115 citations
  2. 2Increased antifungal activity of L-733,560, a water-soluble, semisynthetic pneumocandin, is due to enhanced inhibition of cell wall synthesis1994 · 71 citations
  3. 3Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies1996 · 137 citations
  4. 4Identification of Yeast Rho1p GTPase as a Regulatory Subunit of 1,3-β-Glucan Synthase1996 · 454 citations
  5. 5Synthesis and Antifungal Activity of Novel Cationic Pneumocandin Bo Derivatives1994 · 113 citations